PCVX

Vaxcyte, Inc. - Common Stock (PCVX)

About Vaxcyte, Inc. - Common Stock (PCVX)

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Details

Daily high

$60.20

Daily low

$58.21

Price at open

$60.07

52 Week High

$65.00

52 Week Low

$30.81

Market cap

8.8B

Dividend yield

Volume

1.7M

Avg. volume

1.0M

P/E ratio

-7.71

Vaxcyte, Inc. - Common Stock News